Myocene Sensivity to Cycling Intensities
April 2, 2025 updated by: Filipe Silvano Pinto Maia, University of Maia
Muscular Response to Short vs. Prolonged Cycling: A Crossover Trial on Low-Frequency Fatigue Sensitivity
This study aims to address this gap by assessing LFF following different efforts in cycling, aiming to identify a pattern.
Also, we expect that this study helps to clarify to which efforts (prolonged vs short) are more likely to trigger substantial changes in LFF responses.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Road cyclists
Exclusion Criteria:
- Injured or recently injured participants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 4 minutes all-out
4 minute time trial all-out
|
Low frequency fatigue will be measured using Myocene
|
|
Experimental: 30 minute all-out
30 minute cycling all-out
|
Low frequency fatigue will be measured using Myocene
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
low-frequency fatigue
Time Frame: Baseline, 30 minutes post, 24 hours post
|
Low-frequency fatigue assessed using Myocene software, which computes the median value of the ratio between high and low frequency stimulations
|
Baseline, 30 minutes post, 24 hours post
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2025
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
July 1, 2025
Study Registration Dates
First Submitted
March 24, 2025
First Submitted That Met QC Criteria
April 2, 2025
First Posted (Actual)
April 6, 2025
Study Record Updates
Last Update Posted (Actual)
April 6, 2025
Last Update Submitted That Met QC Criteria
April 2, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Myo_sens_001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.